Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, EpiSciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation

Development of electrostrictive P(VDF-TrFE-CTFE) terpolymer for medical applications

Abstract : In the 21st century, cardiovascular diseases became a major cause of mortality, the first in the entire world, the second in France after cancers. Indeed, cardiovascular risk factors have been increasing significantly over the past decades and this phenomenon is ongoing today. These factors cause atherosclerosis and lead to coronary acute syndrome, heart attacks, cerebrovascular accident, renal insufficiency but also to peripheral arterial disease (PAOD) and arterial aneurysms. First line treatment of atherosclerosis, regardless of arterial territory concerned, is medical treatment. But, if despite best medical treatment, symptoms are important for patients, interventional treatment may be considered. For aneurysms and for PAOD, vascular surgery is possible. Vascular surgery can be divided into two categories: conventional open repair (COR) and endovascular techniques (ET). During the last ten years, ET became the first line treatment for most arterial injuries. ET has become the first line treatment because it allows a considerable reduction in surgical morbi-mortality and a great reduction in health costs.
Document type :
Complete list of metadata
Contributor : ABES STAR :  Contact
Submitted on : Wednesday, March 31, 2021 - 5:16:08 PM
Last modification on : Monday, November 29, 2021 - 11:12:03 AM
Long-term archiving on: : Thursday, July 1, 2021 - 7:02:06 PM


Version validated by the jury (STAR)


  • HAL Id : tel-03187162, version 1


Nellie Della-Schiava. Development of electrostrictive P(VDF-TrFE-CTFE) terpolymer for medical applications. Biotechnology. Université de Lyon, 2020. English. ⟨NNT : 2020LYSEI112⟩. ⟨tel-03187162⟩



Record views


Files downloads